Treatment of autoimmune ophthalmopathy syndrome

Cover Page

Cite item

Full Text

Abstract

The treatment of autoimmune ophthalmow pathy by the high doses (pulse-therapy) or glucocorticoids in terms of interrupted courses (3 days cycles in every 7—10 days and in 1 —1,5 months later on) may be successfully used in clinical practice. Pulse-therapy in the treatment of autoimmune ophthalmopathy syndrome is primarily recommended in the heavy course of the disease. Roentgenotherapy on the orbit region is prescribed in case of the insufficient effect.

About the authors

V. V. Talantov

Kazan Order of the Red Banner of Labor of the Medical Institute named after S.V. Kurashov; Republican Clinical Hospital M3 RT

Author for correspondence.
Email: info@eco-vector.com
Russian Federation

E. N. Khasanov

Kazan Order of the Red Banner of Labor of the Medical Institute named after S.V. Kurashov; Republican Clinical Hospital M3 RT

Email: info@eco-vector.com
Russian Federation

R. L. Shamsutdinova

Kazan Order of the Red Banner of Labor of the Medical Institute named after S.V. Kurashov; Republican Clinical Hospital M3 RT

Email: info@eco-vector.com
Russian Federation

I. F. Gilmullin

Kazan Order of the Red Banner of Labor of the Medical Institute named after S.V. Kurashov; Republican Clinical Hospital M3 RT

Email: info@eco-vector.com
Russian Federation

References

  1. Зефирова Г. С., Кондратьева Л. В., Войчек Э. А., Климов И. И. II Всероссийский съезд эндокринологов,—Челябинск, 1991.
  2. Кандрор В. В., Бирюкова М. П., Крюкова И. В. и др. Пробл. эндокринол.—1990.; № 4,—С. 78—83.
  3. Руководство по клинической эндокринологии. Под ред. акад. В. Г. Баранова.—Л., 1977.
  4. Kanaly G., Schuler М., Sewell А. С. et аl. Clin. Endocrinol.—1990.—Vol. 33.— Р. 35—44.
  5. Shine В., Fells Р., Edwards О. М., Weetman A. P. Lancet.—1990,—Vol. 335. Р. 1261 — 1263.

© 1993 Talantov V.V., Khasanov E.N., Shamsutdinova R.L., Gilmullin I.F.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies